The platform will undergo maintenance on Sep 14 at about 9:30 AM EST and will be unavailable for approximately 1 hour.
2014
DOI: 10.1097/gco.0000000000000107
|View full text |Cite
|
Sign up to set email alerts
|

Fertility preservation and reproductive health in the pediatric, adolescent, and young adult female cancer patient

Abstract: A systematic approach to fertility preservation prior to treatment in all patients receiving gonadotoxic agents optimizes care. Fertility preservation strategies can restore hormonal function and preserve reproductive potential. Future research in personalizing approach to care is critical to meeting the needs of this patient population.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
9
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 26 publications
(12 citation statements)
references
References 51 publications
0
9
0
Order By: Relevance
“…On the other hand, several classic risk factors were not associated for a number of potential reasons. Age was not associated possibly due to the fact that this was a relatively young population (median age of 48) where age-related effects on BMD may have been introduced prematurely as a result of chemotherapy, radiation, transplant, and steroid use (50-52). Furthermore, we believe that effects of hypogonadism and other endocrine dysfunction were not associated because they may also have been attenuated by the strength of the treatment-related effects.…”
Section: Discussionmentioning
confidence: 99%
“…On the other hand, several classic risk factors were not associated for a number of potential reasons. Age was not associated possibly due to the fact that this was a relatively young population (median age of 48) where age-related effects on BMD may have been introduced prematurely as a result of chemotherapy, radiation, transplant, and steroid use (50-52). Furthermore, we believe that effects of hypogonadism and other endocrine dysfunction were not associated because they may also have been attenuated by the strength of the treatment-related effects.…”
Section: Discussionmentioning
confidence: 99%
“…For example, fertility preservation (defined as egg, embryo, or ovarian tissue cryopreservation) for young women with cancer who are at-risk for fertility loss has gained wide acceptance, and egg and embryo cryopreservation are now considered standards in clinical practice (Loren et al, 2013; Practice Committees of the American Society for Reproductive Medicine and the Society for Assisted Reproductive Technology, 2013). Egg and embryo cryopreservation are typically performed in conjunction with ovarian stimulation prior to the onset of cancer treatment (Kasum, Beketić-Orešković, Peddi, Orešković, & Johnson, 2014; Trudgen & Ayensu-Coker, 2014). Ovarian tissue cryopreservation is an experimental option that when performed within a research protocol can be appropriate for young women who urgently need to undergo chemotherapy and/or radiation treatment (Practice Committee of the American Society for Reproductive Medicine, 2014).…”
mentioning
confidence: 99%
“…The degree of damage is related to the chemotherapy agent and dose 343 and site of radiotherapy 332 . Alkylating agents are particularly gondadotoxic and can cause long-term fertility impairment in both sexes and premature menopause in women 344,345 .…”
Section: Fertility Issuesmentioning
confidence: 99%
“…In addition, pelvic radiotherapy in women is associated with sexual dysfunction issues both pre-conception and during pregnancy 344,345 , while radiotherapy to the testes causes permanent impairment of sperm production in male patients 332 (see also Chapter 4).…”
Section: Fertility Issuesmentioning
confidence: 99%